Pacific Biosciences of California is back in focus as analysts adjust their price targets by increments of $0.50, reflecting ...

View Pacific Biosciences of California, Inc. PACB stock quote prices, financial information, real-time forecasts, and company news from CNN.

PACB launched a joint FFPE workflow with Covaris to improve the sequencing of archived tumor samples. The solution enhances DNA recovery, boosting structural variant detection and mutation phasing ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss of $0.12 per share was 14.2% above analysts’ ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On ...

PacBio reported Q4 revenues of $44.6M, up 13.8%, beating estimates. PACB's adjusted gross margin expanded 900 bps to 41%, operating loss narrowed. PACB guides 2026 revenue to $165-$180M, up 3-12% year ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results , with sales up 10.4% year on year to $39.77 million. Its non-GAAP loss of $0.13 per share was 21.5% above ...

PacBio and Intus Bio have launched GutID, the first commercial human gut health test, showcasing their collaboration and innovation in microbiome research. GutID utilizes PacBio's HiFi sequencing ...

(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...

Pacific Biosciences of California (PACB) shares fell 16% after the company reported Q1 results that included a wider-than-expected revenue miss and weaker profitability metrics. PacBio reported Q1 non ...

Live webcasts of the events can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the event. PacBio ...